Cause of death, by non-communicable diseases, ages 15-59, female in Senegal
Senegal: Cause of death, by non-communicable diseases, ages 15-59, female was 51.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, female in Senegal, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59, female in Senegal stood at 51.9%.
The figure is down 6.4% on the previous year and up 1.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Senegal peaked at 57.7% in 2019 and was at its lowest, 42.9%, in 2000.
That places Senegal 126th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59, female in Senegal, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 42.9% | — |
| 2010 | 51.0% | +18.8% |
| 2015 | 54.0% | +6.0% |
| 2019 | 57.7% | +6.8% |
| 2020 | 55.5% | -4.0% |
| 2021 | 51.9% | -6.4% |
Senegal compared with similar countries
- Senegal's 51.9% is above the median for lower middle income countries, which is 51.9%, 1.0× the median. (47 countries reporting)
- Senegal's 51.9% is above the median for Sub-Saharan Africa, which is 41.7%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.9% | 42.9% | 42.9% | 1 |
| 2010s | 54.2% | 51.0% | 57.7% | 3 |
| 2020s | 53.7% | 51.9% | 55.5% | 2 |
Countries ranked near Senegal
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Senegal?
- Cause of death, by non-communicable diseases, ages 15-59, female in Senegal was 51.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Senegal?
- The highest recorded value was 57.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Senegal?
- The lowest recorded value was 42.9% in 2000.
- How does Senegal rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Senegal ranks 126th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Senegal?
- Over the last ten years it is up 1.8%. The long-run trend across the full record is rising.
- Where does this Senegal data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.